Jacobs Levy Equity Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-11,272
| Closed | -$1.28M | – | 1124 |
|
|
2020
Q4 | $1.28M | Buy |
11,272
+5,469
| +94% | +$622K | 0.01% | 665 |
|
|
2020
Q3 | $694K | Buy |
5,803
+2,501
| +76% | +$299K | 0.01% | 726 |
|
|
2020
Q2 | $411K | Buy |
3,302
+2,617
| +382% | +$326K | ﹤0.01% | 820 |
|
|
2020
Q1 | $132K | Sell |
685
-109
| -14% | -$21K | ﹤0.01% | 938 |
|
|
2019
Q4 | $265K | Sell |
794
-212
| -21% | -$70.8K | ﹤0.01% | 883 |
|
|
2019
Q3 | $324K | Sell |
1,006
-579
| -37% | -$186K | ﹤0.01% | 769 |
|
|
2019
Q2 | $684K | Buy |
1,585
+128
| +9% | +$55.2K | 0.01% | 696 |
|
|
2019
Q1 | $823K | Buy |
1,457
+113
| +8% | +$63.8K | 0.01% | 702 |
|
|
2018
Q4 | $399K | Buy |
+1,344
| New | +$399K | 0.01% | 773 |
|